Profile

Cover photo
Verified name
Sally Church
Works at Icarus Consultants
5,138 followers|65,649 views
AboutPostsPhotosYouTube

Stream

Sally Church

Shared publicly  - 
 
Novel targets in urothelial bladder cancer may offer options for new antibody and CAR-T cell therapy development
1
Add a comment...
 
Some new exciting combination approaches are likely to emerge soon...
Early data from ASH 2014 suggests that monotherapy with checkpoint inhibitors will not be sufficient so where do we go next?
1
Add a comment...

Sally Church

Shared publicly  - 
 
The trials in this market are on the move again...
Dr Krishna Komanduri discusses CAR-T Cell Therapy GVHD and Gene Therapy abstracts at BMT Tandem meeting in San Diego
1
Add a comment...
 
This work could have a huge implication for future clinical trial design in colon cancer...
Precision medicine approaches may be possible in colorectal cancer if we can identify new subsets and treat with targeted therapies
1
Add a comment...
 
Adoptive cell therapies are a hot topic in cancer research
Future of Cancer Immunotherapy with Tumor Infiltrating Lymphocytes, Chimeric Antigen Receptors and T Cell Receptors
1
Add a comment...
 
The T790M lung cancer market is really hotting up...
Clovis Oncology Rociletinib CO-1686 shows activity in T790M negative non small cell lung cancer
1
Add a comment...
Have them in circles
5,138 people
keita ismael's profile photo
Solomon Mwangi's profile photo
Jhake Anthony's profile photo
Daniel Kraszkiewicz's profile photo
Andy Badera's profile photo
cathy duncam's profile photo
Ian R McAllister's profile photo
Lance Tracey's profile photo
Sue Searle's profile photo

Sally Church

Shared publicly  - 
 
Potential of EBV-CTL T-Cell Therapy for Epstein-Barr Virus Lymphoproliferative Disorders
1
Sushil Sharma's profile photo
 
Job in Pharmacist
Add a comment...
 
I think we will start seeing more combination approaches emerge that will shift outcomes for cancer patients...
Improved survival was seen in advanced prostate cancer when Prostvac was combined with ipilimumab
1
Add a comment...

Sally Church

Shared publicly  - 
 
Which new combinations could improve outcomes for colon cancer patients receiving EGFR therapies?
1
Add a comment...

Sally Church

Shared publicly  - 
 
Some interesting news here plus the stock has shot up...
Chimeric Antigen Receptor CAR T Cell therapies from China pose a competitive threat to Juno, Kite, Bellicum, Novartis
1
Add a comment...

Sally Church

Shared publicly  - 
 
One to watch out for at ASCO and ASH this year...
Does ABT-199 venetoclax have potential in hematologic malignancies and CLL?
1
Add a comment...

Sally Church

Shared publicly  - 
 
A novel and exciting approach to R&D could like to some good results in a hard to treat cancer
Understanding MYCN as a critical driver is crucial to developing novel cancer therapies via CDK7 inhibition
1
1
Neuromics Pete Shuster's profile photo
Add a comment...
People
Have them in circles
5,138 people
keita ismael's profile photo
Solomon Mwangi's profile photo
Jhake Anthony's profile photo
Daniel Kraszkiewicz's profile photo
Andy Badera's profile photo
cathy duncam's profile photo
Ian R McAllister's profile photo
Lance Tracey's profile photo
Sue Searle's profile photo
Work
Occupation
Management Consultant
Employment
  • Icarus Consultants
    Management Consultant, present
  • Novartis
  • Sandoz UK
Story
Introduction
Who am I?
I'm a marketer, a scientist, a maverick, a consultant and a problem solver.

What do I do?
People come to me with their problems and we find creative solutions.  I'm a science and data geek we make data sing.

What sort of problems? 
Strategic marketing, competitive intelligence, landscape opportunity assessments, KOL market research, social media monitoring.  Find out more detail here

What sort of clients? 
Pharma and biotechnology companies. 
We specialise in oncology and hematology, but have also completed projects in immunology, diabetes, respiratory, CNS and many others.

How can you find or contact me?
Via my blog